Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study-Reference-Cited by-同舟云学术

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

Published:2009-11-12 Issue:1 Volume:33 Page:41-52
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Lammer Johannes,Malagari Katarina,Vogl Thomas,Pilleul Frank,Denys Alban,Watkinson Anthony,Pitton Michael,Sergent Geraldine,Pfammatter Thomas,Terraz Sylvain,Benhamou Yves,Avajon Yves,Gruenberger Thomas,Pomoni Maria,Langenberger Herbert,Schuchmann Marcus,Dumortier Jerome,Mueller Christian,Chevallier Patrick,Lencioni Riccardo,

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00270-009-9711-7.pdf

Reference33 articles.

1. Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485–1491

2. Höpfner M, Schuppan D, Scherübl H (2008) Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World J Gastroenterol 14:1–14

3. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 19:329–338

4. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35:519–524

5. O’Neil BH, Venook AP (2007) Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. Oncologist 12:1425–1432

Cited by 1341 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current research status of transarterial therapies for hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-09-15

2. Embolic and Ablative Therapy for Hepatocellular Carcinoma;Clinics in Liver Disease;2024-09

3. Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study;JHEP Reports;2024-09

4. Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective;World Journal of Gastroenterology;2024-08-21

5. Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma;Pharmaceuticals;2024-08-11